The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development

E-ISSN： 1875-6646|10|2|124-130

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.10, Iss.2, 2014-07, pp. : 124-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Modulating Effects of Endogenous Substances on Drug Metabolising Enzymes and Implications for Inter-Individual Variability and Quantitative Prediction

Current Drug Metabolism, Vol. 15, Iss. 6, 2014-07 ,pp. : 599-619

Bentham Science Publishers

Access to resources Recommend Favorite

Modulating Cell Cycle: Current Applications and Prospects for Future Drug Development

Current Cancer Drug Targets, Vol. 2, Iss. 4, 2002-12 ,pp. : 309-336

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoid-Related Enzymes as Drug Targets with Special Reference to N-Acylphosphatidylethanolamine-Hydrolyzing Phospholipase D

Current Medicinal Chemistry, Vol. 12, Iss. 12, 2005-06 ,pp. : 1413-1422

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention

Current Drug Metabolism, Vol. 10, Iss. 6, 2009-07 ,pp. : 595-616

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Insights for Drugs Developed for Phospholipase D Enzymes

Current Drug Discovery Technologies, Vol. 15, Iss. 2, 2018-04 ,pp. : 81-93

Bentham Science Publishers

Access to resources Recommend Favorite